Executive Summary
Across 120 filings on February 9, 2026, a massive cluster of ~65 Item 5.02 disclosures for officer/director changes (avg materiality 4/10, neutral sentiment) across sectors like banking (e.g., FIRST BANCORP/PR, Glacier Bancorp), biotech (Ocugen, IN8BIO), and energy (EQT, EXPAND ENERGY) signals potential routine governance refreshes or hidden instability amid no disclosed quantitative impacts. ~35 high-materiality (avg 8/10) Item 1.01 material definitive agreements (e.g., ProCap Financial, Nauticus Robotics, AMC Entertainment) alongside ~10 acquisitions/dispositions (Item 2.01, e.g., Waters Corp, XOMA Royalty) indicate robust M&A/deal activity, though undisclosed terms limit assessment. Critical bearish outliers include 4 delisting notices (Generation Bio mixed/high risk 10/10, Curis/VolitionRx/374Water bearish/critical 10/10) and insolvencies/administrations (Future Enterprises x2, 6 Unknowns medium 6/10 bearish). Neutral sentiment dominates (95% of filings), with no period-over-period metrics, insider trades, guidance, or capital allocation data disclosed across the board; Indian filings (e.g., Nirbhay Colours open offers x2, Aadhar open offer) highlight takeover bids. Portfolio implications: active M&A flow bullish for deal arbitrage, but leadership churn and delistings warrant short-term caution; prioritize exhibit reviews for alpha.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from February 07, 2026.
Investment Signals(12)
- ProCap Financialβ(BULLISH)β²
Multi-item 8-K incl Item 1.01 material agreement + Item 2.01 acquisition completion + Item 3.02 equity sales (medium risk 8/10 materiality) signals strategic expansion despite dilution risk
- Nauticus Roboticsβ(BULLISH)β²
Item 1.01 material agreement + Item 2.03 financial obligation + Item 3.02 equity dilution + Item 5.03 governance amendments (medium risk 8/10) potential funding catalyst
- Waters Corpβ(BULLISH)β²
Item 1.01 material agreement + Item 2.01 acquisition completion + Item 2.03 obligation (medium risk 9/10 materiality, 3MB filing) accretive deal flow
- AMC Entertainmentβ(BULLISH)β²
Item 1.01 material agreement + Item 8.01 other events (medium risk 9/10 materiality) turnaround potential post-restructuring
- XOMA Royaltyβ(BULLISH)β²
Item 2.01 acquisition/disposition completion + Item 7.01 Reg FD (medium risk 8/10) portfolio optimization
- Seaport Entertainmentβ(BULLISH)β²
Item 2.01 asset disposition completion + Item 7.01 Reg FD (medium risk 8/10) deleveraging move
- Generation Bioβ(BEARISH)β²
Mixed sentiment high materiality 10/10 with Item 5.01 change in control + Item 2.01 asset completion offset by delisting risk
- Curis Incβ(BEARISH)β²
Item 3.01 delisting notice (bearish critical risk 10/10 materiality) liquidity erosion imminent
- VolitionRx Ltdβ(BEARISH)β²
Item 3.01 delisting/transfer notice (bearish critical risk 10/10) compliance failure signals distress
- 374Water Incβ(BEARISH)β²
Item 3.01 delisting + Item 5.02 officer change (bearish high risk 9/10) dual governance/compliance crisis
- Future Enterprises Limitedβ(BEARISH)β²
Dual insolvency filings (medium risk 6/10 x2) restructuring uncertainty
- β²
Bearish administration entry under Corporations Act (10/10 materiality) + CIO retirement signals distress
Risk Flags(10)
- Officer Change Cluster (65+ cos e.g., NXP, Phoenix Motor, EQT, Verizon)[HIGH RISK]βΌ
Undisclosed names/positions/reasons across ~65 filings (avg low-med risk 3-5/10) potential governance instability wave
- Nauticus Roboticsβ[HIGH RISK]βΌ
Item 3.02 unregistered equity + Item 3.03 security rights mods + Item 5.03 bylaws changes (med risk 8/10) dilution + control shift
- Nature's Miracleβ[MEDIUM RISK]βΌ
Item 3.02 equity sales + undisclosed Item 5.02 changes (med risk 6/10) dilution + leadership uncertainty
- Generation Bioβ[CRITICAL RISK]βΌ
Item 3.01 delisting + Item 1.02 agreement termination + Item 3.03 rights mods (high risk 10/10 mixed) public status loss
- Curis Incβ[CRITICAL RISK]βΌ
Item 3.01 delisting notice alone (critical risk 10/10 bearish) exchange removal
- 374Water Incβ[HIGH RISK]βΌ
Item 3.01 delisting + Item 1.01 undisclosed agreement + Item 5.02 changes (high risk 9/10 bearish) multi-front crisis
- VolitionRx Ltdβ[CRITICAL RISK]βΌ
Item 3.01 delisting/transfer (critical risk 10/10 bearish) liquidity/visibility drop
- βΌ
Medium risk 6/10 cluster signals sector distress patterns
- Sherwin-Williamsβ[MEDIUM RISK]βΌ
Item 2.03 new financial obligation undisclosed terms (med risk 8/10) balance sheet deterioration potential
- Adani Enterprises (#14)[MEDIUM RISK]βΌ
Rights issue outcome disclosed sans quantum/pricing/record date (neutral med 6/10) dilution risk opacity
Opportunities(10)
- ProCap Financial/Acquisitionβ(OPPORTUNITY)β
Item 2.01 completion + Item 1.01 agreement (8/10 mat) synergies pending exhibits
- Functional Brands/Material Agreementβ(OPPORTUNITY)β
Item 1.01 high materiality 8/10 timely filing potential strategic pivot
- La Rosa Holdings/Material Agreementβ(OPPORTUNITY)β
Item 1.01 + voluntary Item 8.01 (med risk 8/10) growth catalyst
- SHF Holdings/Reg FD + Agreementβ(OPPORTUNITY)β
Item 7.01 + Item 1.01 (med risk 8/10) forward guidance potential
- Limitless X/Financial Obligationβ(OPPORTUNITY)β
Item 2.03 + Item 1.01 (med risk 8/10) funding for expansion
- LVPAI Group/Material Agreementβ(OPPORTUNITY)β
Item 1.01 (med risk 7/10) undisclosed positive terms possible
- Crimson Wine/Acquisitionβ(OPPORTUNITY)β
Item 2.01 completion + Item 7.01 (med risk 8/10) portfolio enhancement
- CION Investment/Material Agreementβ(OPPORTUNITY)β
Item 1.01 high med 7/10 strategic development
- SPACSphere Acquisition/Mergerβ(OPPORTUNITY)β
Item 1.01 + Item 3.02 equity (med risk 8/10) SPAC de-SPAC arbitrage
- Once Upon a Farm/Material Agreementβ(OPPORTUNITY)β
Item 1.01 despite governance changes (med risk 8/10) growth enabler
Sector Themes(6)
- Executive Turnover Surge(WATCH GOVERNANCE)β
~65 filings (e.g., 28 Phoenix Motor to 119 GigCapital9) Item 5.02 undisclosed changes avg low materiality 4/10 across banks/biotech/energy/gold trusts; implies routine refresh but cluster raises instability flags for small/mid caps
- M&A/Deal Flow Acceleration(BULLISH PIPELINE)β
35+ Item 1.01 material agreements (avg 8/10 mat, e.g., ProCap to Clear Channel) + 10 Item 2.01 acqs (Waters, Seaport); neutral sentiment suggests healthy activity despite opacity, alpha in exhibit dives
- Delisting/Compliance Distress(BEARISH SMALL CAPS)β
4 critical bearish Item 3.01 (Generation Bio 10/10 mixed, Curis/Volition/374Water 10/10); small caps overrepresented, liquidity traps post-event
- Dilution via Equity Sales(MIXED FUNDING)β
10+ Item 3.02 unregistered sales (e.g., Nauticus, Nature's Miracle, Liminatus) tied to deals; med-high risk avg 7/10, balance sheet fortification vs shareholder pain
- Banking Leadership Shifts(NEUTRAL SECTOR ROTATION)β
10+ banks (FIRST BANCORP/PR #33, Commerce #62, Glacier #91, Regions #101 etc.) Item 5.02 low risk 3-5/10; potential rate environment response sans metrics
- Biotech/Pharma Churn(HIGH VOLATILITY)β
15+ (Ocugen #38, Predictive Oncology #40, Trisalus #53, Entera Bio #50, Volition #114 delist); med risk 5/10 avg + delists signal funding squeezes
Watch List(8)
High risk 10/10 mixed, monitor exhibits/Item 3.01 timeline for OTC transfer impact Feb 2026
Critical bearish 10/10, watch exchange response + shareholder vote outcomes immediate
High risk 9/10 bearish, track Item 1.01 agreement details for rescue potential
Critical 10/10, monitor liquidity post-listing shift Feb 2026
Med risk 8/10 Item 3.02/5.03 dilution + amendments, review exhibits for shareholder rights impact
9/10 mat, high profile watch for deal terms/exhibits on restructuring alpha
9/10 mat Item 2.01 completion, monitor integration + Item 2.03 obligation covenants
Med 6/10 #14+15+52, track follow-up BSE filings for quantum/pricing/record date
Filing Analyses(120)
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
Adani Enterprises Limited announced the outcome of the Rights Issue Committee meeting held on Monday, February 9, 2026, as per BSE filing. No specific details on the rights issue such as quantum, pricing, record date, entitlement ratio, or fund utilization were disclosed. This informational disclosure provides no quantitative financial metrics or period-over-period comparisons.
- Β·Event pertains to Rights Issue Committee meeting outcome
- Β·Filing source: BSE
- Β·BSE scrip code: 512599
09-02-2026
09-02-2026
09-02-2026
10-02-2026
09-02-2026
09-02-2026
NXP Semiconductors N.V. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
09-02-2026
ProCap Financial, Inc. filed an 8-K on 2026-02-09 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 3.02 unregistered sales of equity securities, Item 5.02 departure/election of directors or appointment of officers including compensatory arrangements, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial terms, parties involved, synergies, or performance metrics were detailed.
09-02-2026
The company filed an 8-K on February 9, 2026 (AccNo: 0001851048-26-000002), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the officer's name, title, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
09-02-2026
Functional Brands Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001213900-26-013392, Size: 221 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial metrics, positive or negative impacts, or named entities are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.
09-02-2026
09-02-2026
La Rosa Holdings Corp. filed a Form 8-K on 2026-02-09 reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits (file size 4 MB). This is a multi-item filing with both mandatory (Item 1.01) and voluntary (Item 8.01) disclosures, filed on the event date suggesting timely compliance within the 4-business-day requirement. No specific details on the agreement, events, transaction value, financial impacts, or exhibits are disclosed in the provided information.
09-02-2026
Nature's Miracle Holding Inc. filed a Form 8-K on 2026-02-09 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), with financial statements and exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the agreement, equity sales, or personnel changes are disclosed. This multi-item filing signals potential strategic shifts but lacks data to assess positive or negative effects.
09-02-2026
09-02-2026
PHOENIX MOTOR INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, key positions affected (e.g., CEO, CFO), reasons for the change, timing, internal/external status, or any quantitative data are disclosed. Sector is not specified.
- Β·Event date: February 09, 2026
- Β·Filing AccNo: 0001493152-26-005679
- Β·File size: 197 KB
09-02-2026
EDGEWELL PERSONAL CARE Co filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), submission of matters to a vote of security holders (Item 5.07), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, timing, or any quantitative financial metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or governance implications are mentioned.
09-02-2026
EQT Corp filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for change, or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
09-02-2026
Kyndryl Holdings, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the affected position, individual name, appointment or resignation status, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
09-02-2026
Advantage Solutions Inc. filed a Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This multi-item filing includes both mandatory (Item 1.01) and voluntary (Item 7.01) disclosures, but specific details on the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or performance comparisons are provided.
09-02-2026
FIRST BANCORP /PR/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons, or timing were disclosed.
09-02-2026
09-02-2026
09-02-2026
09-02-2026
09-02-2026
Ocugen, Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
09-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-09 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
09-02-2026
Predictive Oncology Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
09-02-2026
EXPAND ENERGY Corp filed an 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details such as the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data like compensation amounts are disclosed. This appears to be a routine disclosure of leadership transition without further context provided.
09-02-2026
Universal Corp /VA/ filed an 8-K on February 9, 2026 (AccNo: 0001628280-26-006200), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, title, reason, or timing, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned.
09-02-2026
PulteGroup Inc/MI/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons, effective dates, or quantitative details were disclosed in the provided filing summary.
09-02-2026
Nauticus Robotics, Inc. filed a multi-item Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This filing indicates multiple significant corporate actions but lacks quantitative data for balanced assessment of positive or negative effects.
09-02-2026
AMC Entertainment Holdings, Inc. filed a Form 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, financial impacts, or quantitative metrics were provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative metrics.
09-02-2026
Labcorp Holdings Inc. filed an 8-K on 2026-02-09 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, or any quantitative data are disclosed in the provided filing summary.
09-02-2026
SHF Holdings, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons are provided in the available information. This is a multi-item filing with no disclosed quantitative impacts.
09-02-2026
IN8BIO, INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are disclosed. No quantitative data, financial metrics, or other changes are mentioned.
- Β·AccNo: 0001193125-26-041975
- Β·File size: 140 KB
- Β·Event date: 2026-02-09
- Β·Sector: NOT_DISCLOSED
09-02-2026
Workday, Inc. filed a Form 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD disclosure under Item 7.01 and references to financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or any quantitative data are disclosed.
09-02-2026
Entera Bio Ltd. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
09-02-2026
Limitless X Holdings Inc. filed an 8-K on 2026-02-09 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 discloses financial statements and exhibits. No specific details on transaction terms, values, parties, or impacts are provided.
09-02-2026
09-02-2026
TriSalus Life Sciences, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.
09-02-2026
09-02-2026
09-02-2026
LVPAI GROUP Ltd filed an 8-K on 2026-02-09 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction details, period-over-period comparisons, or directional impacts are disclosed. This is a multi-item mandatory disclosure with no specified dollar values or strategic context provided.
09-02-2026
Sherwin-Williams Co filed an 8-K on 2026-02-09 under Items 1.01, 2.03, and 9.01, disclosing entry into a material definitive agreement and creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as transaction value, terms, or financial impacts are provided. This is a multi-item mandatory filing with exhibits attached under Item 9.01.
09-02-2026
FIRST MERCHANTS CORP filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, timing, or financial impacts are disclosed.
09-02-2026
World Gold Trust filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003438), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Specific details including key positions affected, individuals involved, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
09-02-2026
SPDR GOLD TRUST filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No financial metrics, quantitative changes, or other impacts are mentioned.
09-02-2026
Northfield Bancorp, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data were provided.
09-02-2026
The company filed an 8-K on February 9, 2026 (AccNo: 0001213900-26-013602), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, reason for departure or appointment, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
09-02-2026
Liminatus Pharma, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific details on the agreement, transaction size, financial impacts, or strategic rationale are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons disclosed.
09-02-2026
Immucell Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001437749-26-003514), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected individuals, positions, reasons, timing, or financial impacts are disclosed.
09-02-2026
Fox Factory Holding Corp filed a Form 8-K on February 9, 2026 (AccNo: 0001424929-26-000002, Size: 408 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no quantitative financial metrics, transaction values, dollar amounts, share counts, percentages, or specific names/details disclosed in the provided information. No positive or negative performance indicators, guidance changes, or market impacts are mentioned.
09-02-2026
Kroger Co filed an 8-K on 2026-02-09 disclosing an officer or director change under Item 5.02, which includes departures, elections, appointments, and compensatory arrangements for certain officers. The filing also contains Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons, or financial impacts are disclosed.
09-02-2026
White Pearl Acquisition Corp. filed an 8-K on 2026-02-09 disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, deal terms, parties involved, financial data, or strategic details are explicitly stated in the provided filing information. Critical transaction specifics remain NOT_DISCLOSED, limiting assessment of impact.
09-02-2026
XOMA Royalty Corp filed an 8-K on 2026-02-09 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses other events under Item 8.01 and provides financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.
09-02-2026
Liquidity Services Inc filed an 8-K on 2026-02-09 (AccNo: 0001193125-26-042756) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or financial terms are disclosed. Sector information is not specified.
09-02-2026
Frontier Group Holdings, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or terms are disclosed.
09-02-2026
Warby Parker Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position, appointment/resignation status, reasons, or timing are provided. No quantitative metrics, performance comparisons, or financial data are mentioned.
09-02-2026
Becton Dickinson & Co filed a Form 8-K on February 9, 2026, disclosing events under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, personnel changes, or quantitative impacts are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative metrics for balanced assessment.
09-02-2026
The company filed an 8-K on February 9, 2026 (AccNo: 0000022606-26-000002), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the officer's name, key position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and any timing or succession information are NOT_DISCLOSED. No quantitative data, financial metrics, governance impacts, board outcomes, or scheduled events are mentioned.
09-02-2026
EQUITY LIFESTYLE PROPERTIES INC filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.
09-02-2026
Waters Corp /DE/ filed an 8-K on February 09, 2026, announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03). The filing also discloses changes in directors or officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and includes financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, parties, or impacts are provided in the available filing information.
- Β·AccNo: 0001193125-26-042819
- Β·Filing Size: 3 MB
- Β·Event Type: Merger/Acquisition
09-02-2026
Team Inc. (TEAM) filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, reasons for change, or any quantitative data were provided.
09-02-2026
TREX CO INC filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the key position affected, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.
09-02-2026
Crimson Wine Group, Ltd. filed an 8-K on 2026-02-09 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific deal terms, financial metrics, parties involved, or performance impacts are disclosed.
09-02-2026
NGL Energy Partners LP filed an 8-K on 2026-02-09 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 includes financial statements and exhibits. No specific details on personnel changes, vote outcomes, reasons, timing, or quantitative metrics are disclosed.
09-02-2026
Resources Connection, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or financial metrics are disclosed.
09-02-2026
DTE Energy Co filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No quantitative data, scheduled events, or other material developments were mentioned.
09-02-2026
SpyGlass Pharma, Inc. filed an 8-K on February 9, 2026, disclosing an officer change or departure of directors under Item 5.02 (including compensatory arrangements of certain officers), amendments to articles of incorporation or bylaws under Item 5.03, and Regulation FD disclosure under Item 7.01. No specific details on positions affected, individuals involved, reasons for changes, timing, or financial impacts are disclosed. Item 9.01 references financial statements and exhibits, but contents are NOT_DISCLOSED.
09-02-2026
Ameren Corp filed an 8-K on February 9, 2026 (AccNo: 0001104659-26-012085), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the affected officer's name, position, reason for change, appointment or resignation status, and any numerical data are NOT_DISCLOSED.
09-02-2026
Tredegar Corp filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED.
09-02-2026
Pebblebrook Hotel Trust filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
09-02-2026
Harmonic Inc. filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-042914), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, reason for change, or timing are disclosed.
09-02-2026
Applied Digital Corp. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, names, reasons for changes, or any quantitative metrics are disclosed.
09-02-2026
IDEX Corporation (IDEX CORP /DE/) filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, internal/external status, or any quantitative data are disclosed. This appears to be a routine governance filing with no additional financial or operational metrics provided.
- Β·AccNo: 0001193125-26-042918
- Β·Filing size: 133 KB
- Β·Event date: February 09, 2026
- Β·Sector: not specified
09-02-2026
CION Investment Corp filed an 8-K on 2026-02-09 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided. Sector is not specified.
09-02-2026
Glacier Bancorp, Inc. filed an 8-K on February 9, 2026 (AccNo: 0000868671-26-000009, Size: 509 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reason for change, effective date, or any compensatory arrangements are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or other numerical data are mentioned.
09-02-2026
Five Below, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual involved, reason for change, or timing are disclosed.
09-02-2026
Planet Fitness, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or any quantitative terms were disclosed. This appears to be an informational filing with no financial metrics, performance comparisons, or directional implications provided.
09-02-2026
Cyngn Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific positions affected, names, reasons, timing, or quantitative details such as compensation amounts are mentioned. No financial metrics, positive or negative changes, or performance comparisons are reported.
- Β·AccNo: 0001213900-26-013688
- Β·File size: 189 KB
- Β·Sector: not specified
- Β·Critical missing information: officer names, titles (e.g., CEO/CFO), action (appointment/resignation), effective dates, reasons for change, compensation details, board composition impact
09-02-2026
Pebblebrook Hotel Trust filed an 8-K on February 9, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, numerical data, or further details are disclosed.
09-02-2026
New America Acquisition I Corp. filed an 8-K on 2026-02-09 under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details, names, dates, financial metrics, or merger/acquisition transaction information are explicitly stated in the provided filing summary. No quantitative data or period-over-period comparisons are disclosed.
09-02-2026
Streamex Corp. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with other events in Item 8.01 and financial statements/exhibits in Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data are disclosed in the provided filing information.
09-02-2026
Generation Bio Co. announced the completion of an acquisition or disposition of assets (Item 2.01) and a change in control of the registrant (Item 5.01), alongside entry into a new material definitive agreement (Item 1.01). However, the filing also discloses termination of a prior material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and material modifications to rights of security holders (Item 3.03), signaling potential loss of public market access. Governance changes include departures or elections of directors/officers (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03).
09-02-2026
Company entered Administration on February 09, 2026, signaling financial distress under Part 5.3A of the Corporations Act 2001 (Cth), likely voluntary administration process managed by an appointed administrator. The announcement also discloses the retirement of the Chief Information Officer, a non-financial event with no disclosed implications for restructuring. Critical details including debt obligations, asset values, creditor hierarchy (secured vs unsecured under s 561), recovery prospects (cents per dollar), timeline expectations, going concern viability, employee entitlements, director liability, and ASIC investigation risks are NOT_DISCLOSED, preventing detailed stakeholder impact assessment.
09-02-2026
Tivic Health Systems, Inc. filed a Form 8-K on 2026-02-09 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement terms, transaction size, parties, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.
09-02-2026
Regions Financial Corp filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, names, reasons, or impacts are disclosed.
09-02-2026
Gold.com, Inc. filed an 8-K on February 9, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement's nature, parties, terms, value, or financial impacts. No quantitative metrics, positive or negative changes, or operational effects are disclosed.
09-02-2026
Radian Group Inc filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD Disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on the officer involved, reason for change, timing, or any quantitative impacts are disclosed.
09-02-2026
Pinterest, Inc. filed an 8-K on February 9, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are mentioned in the provided filing information.
09-02-2026
F&M Bank Corp filed an 8-K on February 9, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for the change, timing, or any quantitative impacts are disclosed. No positive or negative metrics, financial data, or performance comparisons are mentioned in the provided information.
09-02-2026
Curis Inc filed a Form 8-K on 2026-02-09 under Item 3.01, providing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, reasons for delisting, or timelines were disclosed. This is a material negative event signaling potential loss of exchange listing status.
09-02-2026
Playboy, Inc. filed an 8-K on 2026-02-09 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement, transaction value, financial metrics, positive or negative impacts, or performance comparisons were provided in the filing summary.
09-02-2026
UPEXI, INC. filed an 8-K on 2026-02-09 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the summary. No financial metrics, transaction values, or performance comparisons are disclosed.
09-02-2026
Fifth District Bancorp, Inc. filed a Form 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or other quantitative data are disclosed. No positive or negative metrics are present to balance.
09-02-2026
Once Upon a Farm, PBC filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-042994) reporting multiple events: entry into a material definitive agreement (Item 1.01), material modifications to rights of security holders (Item 3.03), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), along with financial statements and exhibits (Item 9.01). This multi-item filing signals significant governance and contractual changes, but no specific transaction details, financial impacts, or quantitative metrics are disclosed.
09-02-2026
CEA Industries Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, appointment or resignation, reasons, or any financial metrics are NOT_DISCLOSED.
09-02-2026
SPACSphere Acquisition Corp. filed an 8-K on February 09, 2026, under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), signaling a merger or acquisition event typical for a SPAC. No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or timelines are disclosed. No positive or negative financial changes are mentioned.
09-02-2026
Seaport Entertainment Group Inc. filed an 8-K on 2026-02-09 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative details, parties involved, strategic rationale, or financial impacts were disclosed.
09-02-2026
VolitionRx Ltd filed an 8-K on February 9, 2026 (AccNo: 0001477932-26-000714), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling potential compliance or financial issues. Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) were also included, but no specific financial metrics, positive developments, or quantitative details were disclosed. No positive or flat metrics were mentioned to offset the delisting notice.
09-02-2026
Greenlane Holdings, Inc. filed a Form 8-K on 2026-02-09 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure filed on the event date.
09-02-2026
K2 Capital Acquisition Corp filed an 8-K on 2026-02-09 (AccNo: 0001213900-26-013760, Size: 402 KB) under Item 9.01 disclosing Financial Statements and Exhibits in connection with a Merger/Acquisition event. No specific details on deal structure, parties involved beyond the filer, valuation, financial metrics, or performance comparisons are explicitly stated in the filing summary. Sector is not specified, and no positive or negative metrics are provided.
09-02-2026
Wellgistics Health, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
09-02-2026
374Water Inc. filed a multi-item Form 8-K on February 9, 2026, reporting entry into a material definitive agreement (Item 1.01), notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01), and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), along with financial statements and exhibits (Item 9.01). The delisting notice signals significant compliance issues with exchange listing standards, which is typically negative, while the material agreement and officer changes lack disclosed details that could imply strategic shifts but carry uncertainty. No financial metrics, transaction values, or quantitative impacts were disclosed.
09-02-2026
GigCapital9 Corp. filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-043037), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are provided. No quantitative financial metrics, performance comparisons, or other corporate actions are mentioned.
09-02-2026
Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-043066), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for key events like material agreements and officer changes, but no specific transaction details, financial metrics, named parties, dollar values, or quantitative impacts are disclosed in the provided information. No positive, negative, or flat performance metrics are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 120 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC